Martin Redhead
About Martin Redhead
Martin Redhead serves as the Associate Vice President at Exscientia, a position he has held since 2024. He has extensive experience in pharmacology, having previously worked as Executive Director of Primary Pharmacology and Head of Quantitative Pharmacology at Exscientia, as well as in leadership roles at UCB and Sygnature Discovery.
Work at Exscientia
Martin Redhead has been with Exscientia since 2020, initially serving as Head of Quantitative Pharmacology until 2023. He transitioned to the role of Executive Director of Primary Pharmacology in 2023. In 2024, he was appointed Associate Vice President. His work focuses on advancing pharmacological strategies and enhancing drug discovery processes within the organization.
Previous Experience at UCB
Before joining Exscientia, Martin Redhead worked at UCB from 2015 to 2020. He held the position of Senior Scientist for three years, followed by a two-year tenure as Group Leader. His roles involved leading research initiatives and contributing to the development of pharmacological solutions.
Experience at Sygnature Discovery
Martin Redhead was employed at Sygnature Discovery from 2012 to 2015 as a Senior Scientist. His responsibilities included conducting research and supporting drug discovery projects, which contributed to his expertise in pharmacology.
Education and Expertise
Martin Redhead earned his Doctor of Philosophy (PhD) in Pharmacy from the University of Nottingham. His academic background provides a strong foundation for his work in pharmacology and drug development, equipping him with the necessary skills to excel in his professional roles.